Shares of Versigent (NYSE:VGNT – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen ratings firms that are covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $54.00.
Several equities research analysts have commented on VGNT shares. Weiss Ratings started coverage on shares of Versigent in a research note on Wednesday, August 5th. They issued a “hold (c)” rating for the company. Zacks Research downgraded Versigent from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 5th. UBS Group reduced their target price on Versigent from $58.00 to $55.00 and set a “buy” rating for the company in a report on Thursday, July 9th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $59.00 price target on shares of Versigent in a research report on Wednesday, August 5th. Finally, Royal Bank Of Canada upgraded Versigent from a “sector perform” rating to an “outperform” rating and lifted their price target for the stock from $41.00 to $52.00 in a report on Wednesday, August 5th.
Get Our Latest Stock Report on Versigent
Versigent Trading Up 3.1%
Versigent (NYSE:VGNT – Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $1.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.58 by $0.34. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.29 billion. As a group, sell-side analysts predict that Versigent will post 7.23 EPS for the current fiscal year.
Versigent Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Friday, September 4th were paid a dividend of $0.13 per share. The ex-dividend date was Friday, September 4th. This represents a $0.52 annualized dividend and a dividend yield of 1.1%.
Insider Transactions at Versigent
In other Versigent news, Director Kevin Clark sold 74,130 shares of the firm’s stock in a transaction on Wednesday, September 9th. The stock was sold at an average price of $45.67, for a total value of $3,385,517.10. Following the completion of the sale, the director directly owned 124,849 shares of the company’s stock, valued at $5,701,853.83. This trade represents a 37.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the company. Integrated Wealth Concepts LLC purchased a new stake in Versigent in the 2nd quarter worth about $57,000. Sequoia Financial Advisors LLC purchased a new stake in Versigent during the second quarter valued at about $220,000. Kintegral Advisory LLC purchased a new stake in Versigent during the second quarter valued at about $224,000. Engineers Gate Manager LP bought a new position in Versigent during the second quarter worth about $418,000. Finally, Corient Private Wealth LP bought a new position in Versigent during the second quarter worth about $426,000.
About Versigent
Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.
See Also
- Five stocks we like better than Versigent
- Can Bloom Energy Pop the Top Off AI’s Massive Energy Bottleneck?
- Coach’s Momentum Powers Tapestry Despite the Stock’s Sharp Pullback
- AI Is Reshaping SaaS—These 2 Software ETFs Offer Different Ways to Play It
- Insiders Signal Deep Value In DICK’s Sporting Goods
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
